Trial Profile
An Open-Label, Randomized, Single-Dose, Parallel-Group Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Moxidectin Administered Orally to Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 May 2014
Price :
$35
*
At a glance
- Drugs Moxidectin (Primary)
- Indications Onchocerciasis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 29 May 2014 New trial record